文献速递骨质疏松与代谢性骨病创伤骨科

三维DXA分腔评估2型糖尿病与糖尿病肾病股骨近端骨

Three-dimensional DXA for compartment-specific assessment of proximal femoral bone in type 2 diabetes and diabetic kidney disease.
PubMed 文献 · Osteoporos Int · 2026-10-29

本研究基于1520名成人(549例T2DM,971例非糖尿病)的3D-DXA重建,比较2型糖尿病与糖尿病肾病患者的股骨近端骨皮质、骨小梁及几何参数。结果显示T2DM的容积骨密度优势在合并DKD且eGFR降低时减弱,全髋屈曲比随eGFR恶化而升高,3D-DXA未改善DKD状态判别,但支持其作为aBMD的补充评估工具。

要点

  • T2DM患者积分、骨小梁及皮质vBMD高于非糖尿病者(β=+9.91、+6.33、+17.64 mg/cm³)。
  • DKD伴eGFR降低者上述vBMD均低于无DKD的T2DM(P<0.03)。
  • 全髋屈曲比与aBMD仅共享7%方差,随eGFR分期升高且独立关联肾功能。

核心结论

  • 3D-DXA可捕捉T2DM与DKD患者股骨近端分腔骨差异,支持其作为aBMD有限时DKD的分腔影像辅助工具进一步评估。
  • 临床转化需前瞻性骨折结局研究。

研究设计与样本

  • 分析1520名成人(549例T2DM,971例非DM)的3D-SHAPER重建,排除影响骨代谢合并症及抗骨吸收或糖皮质激素使用。
  • 采用序贯多变量模型和倾向评分匹配比较T2DM与非DM及四个糖尿病-肾脏状态组,行每SD标准化、Benjamini-Hochberg控制及ROC比较。

主要发现

  • T2DM积分、骨小梁、皮质vBMD高于非DM(β=+9.91、+6.33、+17.64 mg/cm³;FDR q<0.02)。
  • vBMD呈倒U型模式;调整后全队列中DKD伴eGFR降低者上述vBMD低于无DKD的T2DM(P<0.03)。
  • T2DM内全髋屈曲比随eGFR分期升高(G1 3.64至G4 4.64),调整aBMD后仍关联eGFR(P<0.001)和DKD(P=0.007)。
  • 容积参数每SD效应与aBMD相当,3D-DXA未改善DKD状态判别(ΔAUC=0.013;P=0.23)。
  • 探索性PTH×骨小梁交互因DKD状态而异(P=0.039)。

关键数值与推荐

  • T2DM vs 非DM的vBMD差异:积分β=+9.91 mg/cm³、骨小梁+6.33 mg/cm³、皮质+17.64 mg/cm³,FDR q<0.02。
  • DKD伴eGFR降低 vs 无DKD的T2DM:积分、骨小梁、皮质vBMD均更低(P<0.03)。
  • 全髋屈曲比在T2DM内随eGFR分期从G1的3.64升至G4的4.64,与aBMD仅共享7%方差。

临床怎么用

  • 对T2DM合并DKD患者,可考虑3D-DXA评估股骨近端分腔骨密度及几何参数,补充aBMD信息。
  • 全髋屈曲比随eGFR恶化升高,提示肾功能下降时骨几何结构可能变差,需关注骨折风险。

局限性

  • 3D-DXA未显著改善DKD状态判别(ΔAUC=0.013;P=0.23)。
  • PTH与骨小梁交互为探索性假设生成结果。
  • 需前瞻性骨折结局研究验证临床转化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Three-dimensional DXA (3D-DXA), derived from a routine hip DXA, decomposed proximal femoral bone into cortical, trabecular, and geometric components in type 2 diabetes mellitus (T2DM). The apparent T2DM density advantage was attenuated in diabetic kidney disease (DKD), with adjusted analyses showing significantly lower integral, trabecular, and cortical vBMD in DKD with reduced eGFR than in T2DM without DKD. The total-hip buckling ratio, a geometric index sharing only 7% of its variance with areal BMD, rose across worsening eGFR categories within T2DM and remained associated with renal function after adjustment. An exploratory PTH × DKD interaction is reported as hypothesis-generating. These findings support 3D-DXA as a compartment-specific bone-assessment tool that may complement areal bone mineral density in DKD. PURPOSE: Areal bone mineral density (aBMD) performs poorly as a fracture-risk surrogate in diabetic kidney disease (DKD). We evaluated whether three-dimensional DXA (3D-DXA) from a routine hip DXA provides compartment-specific bone phenotyping in type 2 diabetes mellitus (T2DM) and DKD. METHODS: We analysed 3D-SHAPER reconstructions from 1520 adults (549 T2DM; 971 non-DM), excluding bone-affecting comorbidities and antiresorptive or glucocorticoid use. Sequential multivariable models and propensity-score matching compared T2DM with non-DM and four diabetes-kidney status groups, with per-SD standardization, Benjamini-Hochberg control, and receiver-operating-characteristic comparison against total-hip aBMD. RESULTS: T2DM had higher integral, trabecular, and cortical vBMD than non-DM (β = +9.91, +6.33, +17.64 mg/cm³; all FDR q < 0.02). vBMD showed an inverted-U pattern; in the adjusted full cohort, DKD with reduced eGFR had lower integral, trabecular, and cortical vBMD than T2DM without DKD (all P < 0.03). Within T2DM, the total-hip buckling ratio, which shared only 7% of its variance with aBMD, rose across eGFR categories (3.64 at G1 to 4.64 at G4) and remained associated with eGFR (P < 0.001) and DKD (P = 0.007) after adjustment for aBMD. Per-SD effects for volumetric parameters matched aBMD, and 3D-DXA did not improve discrimination of DKD status (ΔAUC = 0.013; P = 0.23). An exploratory PTH-trabecular bone interaction differed by DKD status (P = 0.039). CONCLUSIONS: 3D-DXA from routine hip DXA captured compartment-specific bone differences across diabetes-kidney status groups in T2DM and DKD, supporting its further evaluation as a compartment-specific imaging adjunct to aBMD in DKD where aBMD is limited. Prospective fracture-outcome studies are required for clinical translation.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Choi CJ, Chung YS, Choi YJ, et al. Three-dimensional DXA for compartment-specific assessment of proximal femoral bone in type 2 diabetes and diabetic kidney disease. Osteoporos Int. 2026. PMID: 42955082. doi:10.1007/s00198-026-08249-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。